Litcius/Paper detail

Type 1 diabetes progression is associated with loss of CD3+CD56+ regulatory T cells that control CD8+ T-cell effector functions

Giuseppe Terrazzano, Sara Bruzzaniti, Valentina Rubino, Marianna Santopaolo, Anna Teresa Palatucci, Angela Giovazzino, Claudia La Rocca, Paola de Candia, Annibale Alessandro Puca, Francesco Perna, Claudio Procaccini, Veronica De Rosa, Chiara Porcellini, Salvatore G. De-Simone, V. Fattorusso, Antonio Porcellini, Enza Mozzillo, Riccardo Troncone, Adriana Franzese, Johnny Ludvigsson, Giuseppe Matarese, Giuseppina Ruggiero, Mario Galgani

2020Nature Metabolism38 citationsDOIOpen Access PDF

Topics & Concepts

CD8ImmunologyEffectorT cellCytotoxic T cellBiologyType 1 diabetesPopulationAutoimmunityRegulatory T cellCell biologyIL-2 receptorMedicineAntigenDiabetes mellitusEndocrinologyImmune systemIn vitroGeneticsEnvironmental healthDiabetes and associated disordersImmune Cell Function and InteractionPancreatic function and diabetes
Type 1 diabetes progression is associated with loss of CD3+CD56+ regulatory T cells that control CD8+ T-cell effector functions | Litcius